Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
Cost of Revenue
Trinity Biotech PLC
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trinity Biotech PLC
NASDAQ:TRIB
|
Cost of Revenue
-$37.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
Medtronic PLC
NYSE:MDT
|
Cost of Revenue
-$11.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-10%
|
|
STERIS plc
NYSE:STE
|
Cost of Revenue
-$2.9B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
See Also
What is Trinity Biotech PLC's Cost of Revenue?
Cost of Revenue
-37.4m
USD
Based on the financial report for Dec 31, 2023, Trinity Biotech PLC's Cost of Revenue amounts to -37.4m USD.
What is Trinity Biotech PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
2%
Over the last year, the Cost of Revenue growth was 29%. The average annual Cost of Revenue growth rates for Trinity Biotech PLC have been 11% over the past three years , 8% over the past five years , and 2% over the past ten years .